List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Sonidegib capsules

Skin

Sonidegib capsules, for oral use Initial U.S. Approval: 2015

Generic Name – Relatlimab (Sonidegib)
Medicine Type – Capsules / Oral
Manufacturer Name – Sun Pharma Global Fze
Approval Year – 2015
Approved by – European Medical Agency (EMA), Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import sonidegib Capsules” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Sotorasib Tablets

Lung Cancer

Generic Name: (sotorasib). It is used to treat a type of lung cancer called non-small cell lung cancer (NSCLC).

Sotorasib Tablets is a “used to treat adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) “. LUMAKRAS Tablets is a “prescription medicine. It is available in “form and strength” Tablets: 120 mg.. LUMAKRAS Tablets can be obtained in India upon request.

Facts about your medicine

Name: LUMAKRAS
Active substance: sotorasib tablets
Disease Indications: Lung Cancer
Manufacturer-Amgen Inc.
Usage-Oral Tablets: 120 mg
Medicine Approved By-European Medical Agency (EMA),Food and Drug Administration (FDA),Medicines & Healthcare products Regulatory Agency (MHRA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Enfortumab Vedotin-EJFV for Injection” based on the information you provide.

SOTYKTU (deucravacitinib) tablets

Skin, Solid Tumors

SOTYKTU (deucravacitinib) tablets, for oral use Initial U.S. Approval: 2022

SOTYKTU is an oral prescription medication that is used to treat: Moderate-to-severe plaque psoriasis in adults who may benefit from systemic therapy (pills or injections that work inside the body) or phototherapy (treatment using specialized ultraviolet or UV light).

Brand Name:	SOTYKTU
Generic Name:	deucravacitinib
Strength:	• Tablets: 6 mg
Manufacturer:	Bristol-Myers Squibb
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “SOTYKTU (deucravacitinib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for SOTYKTU (deucravacitinib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

SPEVIGO (spesolimab-sbzo) injection

Skin

SPEVIGO (spesolimab-sbzo) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2022

SPEVIGO (spesolimab-sbzo) is used to treat a severe form of psoriasis (generalized pustular psoriasis). Spesolimab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-36) that may cause inflammation and swelling.

Brand Name:	SPEVIGO
Generic Name:	spesolimab-sbzo
Strength:	For Subcutaneous Use Injection: 150 mg/mL solution in a single-dose prefilled syringe For Intravenous Use Injection: 450 mg/7.5 mL (60 mg/mL) solution in a single-dose vial
Manufacturer:	Boehringer Ingelheim Pharmaceuticals, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “SPEVIGO (spesolimab-sbzo) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for SPEVIGO (spesolimab-sbzo) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Spinraza (Nusinersen)

Neuro, spinal muscular

Spinraza (Nusinersen)

SPINRAZA (nusinersen) is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.

Brand Name:	Spinraza
Generic Name:	Nusinersen
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Spinraza (Nusinersen)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Spinraza (Nusinersen) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

SYNAGIS (palivizumab) injection

Lung Cancer

SYNAGIS (palivizumab) injection

SYNAGIS is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children.

Brand Name:	SYNAGIS
Generic Name:	palivizumab
Strength:	• Single-dose liquid solution vials: 50 mg per 0.5 mL and 100 mg per 1 mL.
Manufacturer:	MedImmune, LLC
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import SYNAGIS (palivizumab) injection” based on the information you provide.

Talazoparib Capsules

Breast Cancer

talazoparib capsules, for oral use Initial U.S. Approval: 2018

Generic Name – Talazoparib
Medicine Type – Capsules/ Oral
Manufacturer Name – Pfizer
Approval Year – 2018
Approved by – Food and Drug Administration (FDA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import
talazoparib capsules” based on the information you provide.

tazemetostat tablets

Solid Tumors

tazemetostat tablets,
for oral use Initial U.S. Approval: 2020

Tazverik (tazemetostat) is a medication used for the treatment of epithelioid sarcoma that is locally advanced (when the cancer is growing outside of the organ, but has not yet spread) or metastasized (when cancer cells have spread to other parts of the body) and that cannot be completely removed by surgery, and for relapsed or refractory follicular lymphoma.

Facts about tazemetostat tablets

Disease Indications-Soft Tissue Sarcoma
Manufacturer-Epizyme inc.
Usage-Oral
Medicine Approved By-Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “tazemetostat tablets” based on the information you provide.

TECENTRIQ (atezolizumab) injection

Breast Cancer, Solid Tumors

Brand Name: Tecentriq Generic Name: (Atezolizumab)
Tecentriq (Atezolizumab) is used to treat patients with locally advanced or metastatic urothelial carcinoma

TECENTRIQ is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-containing chemotherapy, and whose tumors express PD-L1 (PD-L1 stained tumor-infiltrating immune cells [IC] covering ≥ 5% of the tumor area), or are not eligible for any platinum-containing chemotherapy regardless of level of tumor PD-L1 expression, or have disease progression during or following any platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant chemotherapy.

Brand Name:	Tecentriq
Generic Name:	Atezolizumab
Strength:	Injection: 1200 mg/20 mL (60 mg/mL) solution in a single-dose vial.
Manufacturer:	Genentech
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Tecentriq (Atezolizumab)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Tecentriq (Atezolizumab) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

temozolomide for Injection

Solid Tumors

temozolomide for Injection administered via intravenous infusion
Initial U.S. Approval: 1999

TEMODAR is an alkylating drug indicated for the treatment of adult patients with:

Newly diagnosed glioblastoma multiforme (GBM) concomitantly with radiotherapy and then as maintenance treatment.
Refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.

Facts about sotorasib tablets

DISEASE INDICATIONS-Solid Tumor
MANUFACTURER- Merck Sharp & Dohme Corp.
USAGE-5-mg, 20-mg, 100-mg, 140-mg, 180-mg, and 250-mg capsules.
100-mg powder for injection.
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA)

Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “temozolomide for Injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

Sonidegib capsules, for oral use Initial U.S. Approval: 2015

Access the best support services globally

Generic Name: (sotorasib). It is used to treat a type of lung cancer called non-small cell lung cancer (NSCLC).

Facts about your medicine

Access the best support services globally

SOTYKTU (deucravacitinib) tablets, for oral use Initial U.S. Approval: 2022

SPEVIGO (spesolimab-sbzo) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2022

Spinraza (Nusinersen)

SYNAGIS (palivizumab) injection

Access the best support services globally

talazoparib capsules, for oral use Initial U.S. Approval: 2018

Access the best support services globally

tazemetostat tablets, for oral use Initial U.S. Approval: 2020

Access the best support services globally

Brand Name: Tecentriq Generic Name: (Atezolizumab) Tecentriq (Atezolizumab) is used to treat patients with locally advanced or metastatic urothelial carcinoma

temozolomide for Injection administered via intravenous infusion Initial U.S. Approval: 1999

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

tazemetostat tablets,
for oral use Initial U.S. Approval: 2020

Brand Name: Tecentriq Generic Name: (Atezolizumab)
Tecentriq (Atezolizumab) is used to treat patients with locally advanced or metastatic urothelial carcinoma

temozolomide for Injection administered via intravenous infusion
Initial U.S. Approval: 1999